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Summary
Efficiency of interspecies prion transmission decreases
as the primary structures of the infectious proteins
diverge. Yet, a single prion protein can misfold into
multiple infectious conformations, and such differ-
ences in “strain conformation” also alter infection spec-
ificity. Here, we explored the relationship between prion
strains and species barriers by creating distinct syn-
thetic prion forms of the yeast prion protein Sup35. We
identified a strain conformation of Sup35 that allows
transmission from the S. cerevisiae (Sc) Sup35 to the
highly divergent C. albicans (Ca) Sup35 both in vivo
and in vitro. Remarkably, cross-species transmission
leads to a novel Ca strain that in turn can infect the
Sc protein. Structural studies reveal strain-specific
conformational differences in regions of the prion do-
main that are involved in intermolecular contacts. Our
findings support a model whereby strain conforma-
tion is the critical determinant of cross-species prion
transmission while primary structure affects trans-
mission specificity by altering the spectrum of pre-
ferred amyloid conformations.
Introduction
The prion hypothesis was originally proposed to ac-
count for the unusual nature of the infectious agent that
causes mammalian transmissible spongiform encepha-
lopathies (Prusiner, 1982) but has now been expanded
to explain a number of non-Mendelian traits such as
[PSI+] and [URE3] in Saccharomyces cerevisiae and
HET-s in filamentous fungi (Wickner, 1994; Uptain and
Lindquist, 2002; Tuite and Cox, 2003). Although the pri-
mary structures of the infectious proteins in these vari-
ous phenomena are unrelated, they all form similar β
sheet-rich fibrillar aggregates commonly referred to as
amyloid (Prusiner et al., 1998; Dobson, 2001; Chien et
al., 2004). The self-propagating nature of such aggre-
gates has long been postulated to be responsible for
prion inheritance (Aguzzi and Polymenidou, 2004;
Weissmann, 2004). It has recently been shown in fila-
mentous fungi, yeast, and mammals that pure recombi-*Correspondence: weissman@cmp.ucsf.edu
4 Present address: Department of Biology, Massachusetts Institute
of Technology, Cambridge, Massachusetts 02139.nant proteins can act as synthetic prions and that infec-
tion depends on the prion protein misfolding into an
amyloid state (Sparrer et al., 2000; Maddelein et al.,
2002; King and Diaz-Avalos, 2004; Tanaka et al., 2004;
Legname et al., 2004). These results established the
validity of the “protein-only” hypothesis and indicate
that self-propagating amyloids are the infectious form
of prion proteins.
Having established amyloid as the infectious protein
form, we can now begin to explain several universal
and otherwise puzzling features of prion inheritance in
terms of the biochemical/biophysical properties of am-
yloid-based prion replication. For instance, self speci-
ficity in the amyloid propagation results in barriers that
limit prion transmission between different species (Ko-
cisko et al., 1995; Santoso et al., 2000; Vanik et al.,
2004). Similarly, the ability of a single protein to misfold
into more than one amyloid conformation underlies the
prion strain phenomena in which prion particles com-
posed of the same protein lead to distinct infectious
states (King and Diaz-Avalos, 2004; Tanaka et al., 2004;
Legname et al., 2004). While the primary structure of a
prion protein plays critical role in determining its pro-
pensity for cross-species transmission, the specific in-
fectious conformation or strain that a prion protein
adopts also appears to be a major determinant of its
ability to be transmitted between species (Collinge,
2001; Chien et al., 2004). However, the extent to which
and mechanism by which distinct strain conformations
modulate cross-species transmission remain a critical
open question.
The yeast prion [PSI+] provides a powerful system for
investigating the molecular basis of prion inheritance.
The [PSI+] state results from self-propagating aggre-
gates of an essential translation termination factor
Sup35 and leads to a nonsense suppression phenotype
(Uptain and Lindquist, 2002; Tuite and Cox, 2003; Chien
et al., 2004). In yeast containing a nonsense mutation
in the ade1 gene, [PSI+] colonies are white or pink and
grow on media lacking adenine, while [psi−] colonies
are red and require adenine (Chernoff et al., 1995).
[PSI+] propagation is mediated by a modular, N-ter-
minal Gln/Asn-rich sequence and, to a lesser extent, by
a highly charged middle domain (Ter-Avanesyan et al.,
1994; Glover et al., 1997; DePace et al., 1998; Liu et al.,
2002; Bradley and Liebman, 2004). Transient overex-
pression of a fusion between the Sup35 N-terminal and
middle domains (Sup-NM) leads to protein aggregation
and de novo appearance of [PSI+]. Sup-NM also forms
self-seeding amyloid fibers in vitro (Glover et al., 1997;
King et al., 1997), and introduction of these pure fibers
into yeast causes conversion to [PSI+], thus demon-
strating the prion nature of the Sup-NM amyloid state
(King and Diaz-Avalos, 2004; Tanaka et al., 2004).
Like mammalian prions and other yeast prions, [PSI+]
exhibits barriers that restrict interspecies transmission
(Chernoff et al., 2000; Kushnirov et al., 2000a; Santoso
et al., 2000). For example, Sup35 from S. cerevisiae (Sc)
or C. albicans (Ca) each form self-propagating amyloids
in vitro and adopt a heritable prion state in vivo, but
prion forms of the Sc and Ca Sup35 proteins do not
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50appear to cross-seed each other, presumably due to f
their low homology (w40% similarity in the N-terminal b
prion domains). However, species barriers are not ab- c
solute, as cross-seeding between heterologous pro- v
teins can be observed in some instances (Derkatch et w
al., 2001; Derkatch et al., 2004; Nakayashiki et al., 2001; b
Osherovich and Weissman, 2001; Vanik et al., 2004). W
The primary structure of prion proteins is a critical de- t
terminant of the specificity of prion transmission, with c
interspecies infectivity being strongly influenced by the t
degree of similarity between the sequences of two e
prion proteins. S
Prion strains also play a major role in determining the o
specificity of [PSI+] transmission (Chien and Weissman, i
2001; King, 2001; Chien et al., 2003). Like mammalian S
prions and other yeast prions, [PSI+] exhibits a range t
of heritable phenotypic strain variants (Derkatch et al., t
1996). These strains differ in mitotic stability (Derkatch S
et al., 1996), dependence on the cellular chaperone ma- N
chinery (Kushnirov et al., 2000b), and solubility and ac- m
tivity of Sup35 (Derkatch et al., 1996; Zhou et al., 1999; N
Kochneva-Pervukhova et al., 2001; Uptain et al., 2001) b
and lead to differences in the ade1 color phenotype as N
well as in their specificity of transmission. The link be- m
tween prion strains and transmission barriers is likely e
to be general, as the ability of prions to jump species c
barriers appears to differ substantially among mamma- w
lian prion strains (Collinge, 2001; Chien et al., 2004).
The importance of understanding the role of strains in r
modulating specific cross-species transmission has S
been highlighted by the conclusion that a new variant t
of Creutzfeldt-Jacob disease resulted from the cross- e
species transmission to humans of the prion strain re- i
sponsible for bovine spongiform encephalopathy (mad C
cow disease) (Bruce et al., 1997; Hill et al., 1997). Be- p
cause prion strain variability can result from differences t
in the conformation of the infectious protein (King and (
Diaz-Avalos, 2004; Tanaka et al., 2004), the observed m
role of strains in modulating specificity of prion trans- N
mission suggests that amyloid conformation may be an t
important determinant of a prion’s ability to be trans- N
mitted across species barriers. However, until recently, t
the difficulty in creating distinct infectious amyloid 2
forms in vitro and in introducing such synthetic prions f
into an organism has limited the ability to directly ex- N
plore this relationship.
a
In the present study, we take advantage of our ability
c
to create in vitro and infect yeast with distinct prion
cforms (Tanaka et al., 2004) in order to investigate the
irole of Sup35 amyloid conformations in permitting
pcross-species transmission. Remarkably, we identified
oa subset of strain conformations that allow prion trans-
tmission back and forth between the S. cerevisiae and
gC. albicans Sup35 proteins, thus establishing that the
opropensity of a prion for cross-species transmission is
rdetermined by its strain conformation rather than its
iprimary structure.
SResults
C
DSpecificity of Prion Transmission Is Determined
Tby Strain Conformations of a Sc/Ca Chimeric Prion
pWe first explored the role of prion strain conformation
ain determining specificity of prion transmission usinga chimeric Sup-NM (Sup-NMchim), which comprises theirst 40 residues of Sup35 from S. cerevisiae, followed
y residues 47–141 from C. albicans and the highly
harged middle domain (124–253 residues) from S. cere-
isiae (Figure 1A) (Santoso et al., 2000). Sup-NMChim
as previously shown to bridge the species barrier
etween S. cerevisiae and C. albicans (Chien and
eissman, 2001). In vivo, S. cerevisiae yeast in which
he endogenous Sup-NM domain was replaced by one
oding for Sup-NMChim (Chim yeast) could be induced
o form a prion state by transient overexpression of
ither S. cerevisiae Sup-NM (Sup-NMSc) or C. albicans
up-NM (Sup-NMCa). However, the strain phenotypes
f the resulting prion states differed markedly depend-
ng on the species used to induce prion formation.
imilarly, in vitro, when seeded with fibers formed from
he different species of Sup35, Sup-NMChim formed
wo distinct self-propagating amyloid forms, termed
up-NMChim[Sc] (seeded by Sup-NMSc fibers) and Sup-
MChim[Ca] (seeded by Sup-NMCa fibers). These confor-
ations dictate subsequent seeding specificity. Sup-
MChim[Sc] efficiently seeds conversion of Sup-NMSc
ut not Sup-NMCa, while the converse holds for Sup-
MChim[Ca]. These observations are consistent with a
odel in which Sup-NMChim bridges the species barri-
rs in vivo by adopting two amyloid conformations, one
ompatible with S. cerevisiae and the other compatible
ith C. albicans.
To experimentally test the above model, we used our
ecently developed protocol to infect yeast with the two
up-NMChim conformations (Tanaka et al., 2004) by in-
roducing them into prion-free [psi−] yeast expressing
ither wild-type Sc Sup35 (Sc yeast) or a Sup35 variant,
n which the Sc NM domain had been replaced by the
a sequence (Ca yeast). Specificity in the infection ex-
eriment directly mirrored that seen in the earlier in vi-
ro seeding experiments (Chien and Weissman, 2001)
Figure 1B and see Figures S1 and S2 in the Supple-
ental Data available with this article online). Sup-
MChim[Sc] amyloid showed a markedly greater ability
o induce prion formation in Sc yeast than did Sup-
MChim[Ca] amyloid. Consistent with the previous in vi-
ro cross-seeding experiment (Chien and Weissman,
001), Sup-NMChim[Ca] can infect Sc yeast with low ef-
iciency. Conversely, Sup-NMChim[Ca] but not Sup-
MChim[Sc] amyloids could infect Ca yeast (Tanaka et
l., 2004). Importantly, the two Sup-NMChim amyloid
onformations infected Chim yeast with similar effi-
iency but induced different prion strains (Figure 1B,
nset), in agreement with our previous results in which
rion formation in Chim yeast induced by transient
verexpression of Sup-NMSc or Sup-NMCa led to dis-
inct strains (Chien and Weissman, 2001). Taken to-
ether, these studies establish that the conformation
f infectious Sup-NMChim amyloid determines both the
esultant prion strain phenotype and its propensity to
nfect yeast expressing Sup35 from distinct species.
pecific Amyloid Conformations Allow
ross-Seeding between the Highly
ivergent Sc and Ca Sup35 In Vitro
he above studies used an artificial chimeric Sup35
rotein that included sequences derived from both Sc
nd Ca. Potentially, the modular architecture of thisprotein rather than the inherent ability of a single se-
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51Figure 1. Conformation-Dependent, Spe-
cies-Specific Induction of the Prion State by
In Vitro-Converted Sup-NMChim Amyloid
(A) Color-coded schematic of Sup-NMSc
(top), Sup-NMCa (middle), and Sup-NMChim
(bottom) sequences.
(B) Infection of yeast expressing the indi-
cated allele of SUP35 prion domain with
Sup-NMChim amyloid (5 M) formed in the
presence of 5% (w/w) Sup-NMSc (Sup-
NMChim[Sc]) or Sup-NMCa (Sup-NMChim[Ca]) fi-
ber seed. The inset shows examples of typi-
cal Chim prion strain phenotypes induced by
infection with Sup-NMChim[Sc] (left) or Sup-
NMChim[Ca] amyloid (right) on YEPD plates.
Throughout, values with error bars are ex-
pressed as mean ± standard deviation. Note,
as observed previously, experiments involv-
ing Ca yeast show a lower overall infection
efficiency than those involving Sc yeast (Ta-
naka et al., 2004).quence to adopt distinct conformations was responsi-
ble for the cross-seeding and unusual transmission
properties observed. It was therefore important to test
the effect of a prion’s strain conformation on its propen-
sity for cross-species transmission using naturally oc-
curring prion domains. To this end, we produced two
different amyloid conformations of Sup-NMSc by spon-
taneous polymerization at 4°C (Sc4) and 37°C (Sc37),
as previously described (Tanaka et al., 2004). These two
amyloids differ in their thermal stability, protease sus-
ceptibility, and local structure and produce distinct
prion strains when used to infect yeast.
We first explored in vitro whether these two amyloid
conformations differed in their ability to seed polymer-
ization of pure Sup-NMCa protein. Sc37 amyloid failed
to accelerate polymerization of Sup-NMCa, consistent
with the previously reported strong species barrier be-
tween Sc and Ca Sup35 (Figure 2A) (Santoso et al.,
2000). In contrast, addition of Sc4 amyloid shortenedthe lag time of Sup-NMCa polymerization, suggesting
that Sc4 amyloid is capable of cross-seeding Sup-
NMCa. In vivo, spontaneous polymerization is strongly
inhibited, and, thus, much greater differences in the
rate of polymerization in the presence and absence of
an effective seed are expected in cells. Furthermore,
following infection of seeds, cells will have several
hours to recover so that the rate of polymerization seen
in the cross-seeding experiments in vitro is expected
to be sufficient to allow crossinfection in vivo. Finally, if
the observed acceleration in Sup-NMCa polymerization
were due to cross-seeding of Sup-NMCa by Sc4 fibers,
we would expect the resulting Sup-NMCa amyloid to
have a conformation distinct from that of spontane-
ously formed Sup-NMCa fibers. Consistent with this ex-
pectation, we found that the Sup-NMCa fiber formed by
seeding with Sc4 amyloid (Ca[Sc4] amyloid) has lower
melting (T ) and broader transition (W) temperaturesm
(Tm = 73 ± 3°C, W = 24 ± 3°C) than spontaneously
Cell
52Figure 2. A Specific Conformation of Sup-
NMSc Amyloid Can Cross-Seed Sup-NMCa
(A) Amyloid formation of Sup-NMCA mono-
mer in the absence or presence of 20%
(w/w) Sc4 or Sc37 fiber seeds as monitored
by thioflavine T fluorescence.
(B) Thermal stability of Ca[Sc4], Ca2[Sc4],
and spontaneously formed Sup-NMCa (Ca-
spon.) amyloid fibers as determined by pre-
treatment of the fibers at the indicated tem-
peratures in the presence of SDS, followed
by SDS-PAGE and Western blot analysis.
Note that Sup-NMSc and Sup-NMCa mono-
mers can be separated by SDS-PAGE, and
their relative positions are indicated (top).
Below is a schematic of how Ca[Sc4] and
Ca2[Sc4] amyloids are produced.
(C) The band intensities, which reflect sus-
ceptibility of Ca[Sc4], Ca2[Sc4], and Ca-
spon. amyloid fibers to thermal solubiliza-
tion, are plotted against temperature and fit
to a sigmoidal function.formed Sup-NMCa amyloid (Tm = 85 ± 5°C, W = 15 ± a
n2°C) (Figures 2B and 2C). Once templated, the Ca[Sc4]
amyloid conformation is stable and can be propagated
nto a second generation of fibers, termed Ca2[Sc4], that
are formed by seeding polymerization of Sup-NMCa u
swith Ca[Sc4] amyloid: Ca2[Sc4] fibers showed melting
and transition temperatures (Tm = 74 ± 5°C, W = 23 ± e
C5°C) indistinguishable from those of Ca[Sc4] amyloid
(Figures 2B and 2C). These results establish that Sc4 dmyloid is able to cross-seed Sup-NMCa, leading to a
ovel self-propagating amyloid conformation.
Next, we examined the seeding specificity of the
ovel Sup-NMCa conformation. For these studies, we
sed fibers, termed Ca3[Sc4], made by three succes-
ive rounds of seeding and back dilution in order to
liminate any effect of residual Sc4 amyloid in the
a[Sc4] fiber preparations (see Supplemental Data for
etails). As previously observed, spontaneously gener-
Jumping of a Yeast Prion Species Barrier
53ated Sc and Ca amyloid forms are species specific in
their seeding capabilities, and, as expected, Ca3[Sc4]
amyloid is able to seed polymerization of Sup-NMCa
monomer (Figures 3A and 3B). Remarkably, addition of
Ca3[Sc4] seed to Sup-NMSc monomer accelerated the
polymerization of Sup-NMSc (Figure 3A), suggesting that
Ca3[Sc4] amyloid is capable of cross-seeding Sup-NMSc.
Consistent with this proposal, the melting and transi-
tion temperatures (Tm = 71 ± 2°C, W = 22 ± 4°C) of the
resulting Sup-NMSc amyloid, termed Sc[Ca3[Sc4]], are
distinct from those of either the Sc4 or Sc37 fibers (Tm =
56 ± 2°C, W = 27 ± 2°C for Sc4 amyloid, Tm = 77 ± 2°C,
W = 14 ± 1°C for Sc37 amyloid) (Figures 3C and 3D),
indicating that Sc[Ca [Sc4]] amyloid represents yet an-Figure 3. Sup-NMCa Amyloid Fibers Can Cross-Seed Sup-NMSc in a Conformation-Dependent Manner
(A) Amyloid formation of Sup-NMSc in the absence or presence of 5% (w/w) spontaneously formed Sup-NMSc (Sc), spontaneously formed
Sup-NMCa (Ca), or Ca3[Sc4] fiber seeds as monitored by thioflavine T fluorescence.
(B) Amyloid formation of Sup-NMCa in the absence or presence of 5% (w/w) Sc, Ca, or Ca[Sc4] fiber seeds as monitored by thioflavine
T fluorescence.
(C) Thermal stability of Sc[Ca3[Sc4]], Sc4, and Sc37 amyloid fibers.
(D) As in Figure 2C, the band intensities of monomeric Sup-NMSc produced following treatment of Sc[Ca3[Sc4]], Sc4, and Sc37 amyloids at
the indicated temperature in the presence of SDS are plotted against temperature and fit to a sigmoidal function.3other distinct Sup-NMSc amyloid conformation. The
conformational differences between Sc[Ca3[Sc4]], Sc4,
and Sc37 amyloid fibers were further confirmed by dif-
ferences in the spectrum of induced prion strain pheno-
types observed when these amyloids were introduced
into Sc yeast (M.T. and J.S.W., unpublished data).
Taken together, these studies indicate that, as a result
of their conformations, the Sc4 and Ca3[Sc4] fibers are
able to overcome the species barrier that normally pre-
vents cross-seeding between Sup-NMSc and Sup-
NMCa proteins. In addition, our studies establish that
such cross-seeding leads to the generation of novel
amyloid conformations that are compatible with both
Sup-NM and Sup-NM proteins.Sc Ca
Cell
54Figure 4. Structural Analysis of the Various Sup-NM Amyloid Conformations
(A) IR spectra (amide I region) of Sc4 (blue), Sc37 (red), and Sc[Ca3[Sc4]] (black) amyloid fibers. Estimation of secondary structure contents
calculated from each self-deconvoluted spectrum is shown on the right. See Supplemental Data for details.
(B) EPR spectra of Sc4 (blue), Sc37 (red), and Sc[Ca [Sc4]] (black) amyloid fibers spin labeled at positions 46 (left), 88 (middle), and 1173
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55particular, the P1/P2 ratio of residues in the N terminus conformation produced in the cell and are conse-
(right). P1 results from highly immobilized spin probes and P2 results from mobile spin probes.
(C) The relative ratio of the intensities of P1 and P2 (P1/P2) in EPR spectra is plotted against the amino acid position for Sc4 (blue), Sc37
(red), and Sc[Ca3[Sc4]] (black) amyloid fibers.
(D) EPR spectra fully labeled (black) and 50% labeled (gray) Sc37 amyloid fibers. Spectra from fibers labeled at position 36 (left), 76 (middle),
and 108 (right) are shown. EPR spectra were normalized by double integration to the same number of spins.Structural Analysis of the Three Different Sup-NM
Amyloid Conformations
We probed the conformations of Sc4, Sc37, and
Sc[Ca3[Sc4]] amyloid fibers by a range of different bio-
physical methods that report on both global and local
structural features. These studies both demonstrated
that the Sc[Ca3[Sc4]] amyloid represents a novel fiber
conformation and provided structural insights into the
strain-dependent differences in the specificity of prion
propagation. First, we used electron microscopy of
negatively stained amyloid fibers to explore the overall
dimensions of the different strain conformations. Al-
though Sc[Ca3[Sc4]] amyloid tended to have a smoother
appearance, all amyloid fibers exhibited similar mor-
phology (Figure S3), suggesting that there are not large
differences in the quaternary structures of the various
Sup-NM fiber forms. Second, we used Fourier Trans-
form Infrared (FT-IR) spectroscopy to estimate second-
ary structure contents in the amyloid fibers. The IR
spectral shape of Sc4 fibers was similar to that of Sc37
fibers, and deconvolution of the spectra indicated that
they have a similar secondary structure content (Figure
4A). In contrast, there were marked differences in the
IR spectrum of the Sc[Ca3[Sc4]] amyloid indicative of a
higher β sheet content in Sc[Ca3[Sc4]], compared to
Sc4 and Sc37 fibers.
Next, we employed site-directed spin labeling (SDSL)
together with electron paramagnetic resonance (EPR)
spectroscopy to examine localized conformational dif-
ferences at specific amino acids in the Sc4, Sc37, and
Sc[Ca3[Sc4]] amyloid fibers. Earlier studies using SDSL
and EPR revealed structural differences between the
Sc4 and Sc37 fibers (Tanaka et al., 2004). Here, we were
able to substantially improve the quality of the spec-
tra by using a smaller spin probe ([1-Oxyl-2,2,5,5,-
tetramethyl-3-pyrroline-3-methyl] methanethiosulfo-
nate, MTSL) (Hubbell et al., 2000) and a more sensitive
instrument (see Experimental Procedures). We pre-
pared Sup-NM mutants in which a single cysteine resi-
due was substituted into wild-type Sup-NM (which
lacks cysteines) approximately every tenth residue and
labeled them with the cysteine-specific MTSL spin
probe. We then polymerized each of the labeled cys-
teine mutants into the three different Sup-NM fiber con-
formations. EPR spectra revealed a broadening of
peaks as well as the appearance of a new low field
peak (P1) indicative of immobilized side chains and/or
spin-spin interactions in a manner that was strongly de-
pendent on the position of the labeled cysteine residue
(Figures 4B–4D). The degree of immobilization could be
quantitated by taking the ratio of P1 to a second peak
(P2), which is present in the spectra of mobile spin
probes. We observed general structural features com-
mon to both Sc4 and Sc37 fibers as well as local differ-
ences characteristic of specific fiber conformations. In(residues 8–46) and end (residues 117–127) of the prion
domain was higher in Sc37 amyloid fibers than in Sc4
amyloid fibers, suggesting that the amyloid core con-
tains stronger interactions and extends further into
both the N terminus and the C terminus in the Sc37
conformation than in the Sc4 conformation. The SDSL-
EPR analysis also revealed that Sc[Ca3[Sc4]] fibers
were in a conformation distinct from both Sc4 and Sc37
amyloids (Figures 4B and 4C). The most highly immobi-
lized region was shifted from residue 46 to 57 in the
Sc[Ca3[Sc4]] conformation. Furthermore, differences
between Sc[Ca3[Sc4]] and both SC4 and Sc37 fibers
were observed for residues 88–108.
The spectral broadening seen in the various amyloid
forms was also suggestive of spin-spin interactions
that occur when spin labels from different monomers
are within 5–25 Å of each other (Serag et al., 2002). To
explore this possibility, we performed spin dilution ex-
periments in which fibers were prepared with a 1:1 ratio
of labeled and unlabeled Sup-NM focusing on three
residues (36, 76, and 108) from the N-terminal, middle,
and C-terminal regions of the structured core. These
residues showed similar P1/P2 ratios (Figure 4C) so
that the dilution experiments allowed us to distinguish
the relative contribution of spin-spin interactions and
immobilization to P1/P2 values. Spectral differences
between diluted and undiluted samples revealed that
residues 36 and 108 are in close proximity with the cor-
responding residue from other Sup-NM molecules in
the fibers, whereas residue 76 showed no evidence of
spin-spin interactions (Figure 4D). Thus, both the N ter-
minus and the C terminus of the amyloid core are in
proximity to corresponding regions from other Sup-NM
molecules in the fibers. Taken together, these studies
establish that the Sc4, Sc37, and Sc[Ca3[Sc4]] amyloid
forms represent three distinct amyloid conformations
and that at least some of these conformational differ-
ences are in regions likely to be involved in intermolec-
ular interactions between Sup-NM molecules and thus
are well suited to modulate prion specificity.
Specific Amyloid Conformations of Sup35 Jump
Transmission Barriers In Vivo
Having demonstrated conformation-dependent cross-
seeding and conformational differences of Sc Sup-NM
amyloid fibers in vitro, we proceeded to test the ability
of specific Sup-NM amyloid conformations to crossin-
fect in live yeast. Consistent with earlier studies that
found a strong transmission barrier between Sc and Ca
Sup35 (Santoso et al., 2000), transient overexpression
of Sup-NMSc-GFP and Sup-NMCa-GFP fusion proteins
efficiently induced prion formation only in yeast ex-
pressing Sup35 of the same species (Figure 5A). A
drawback of such overexpression experiments, how-
ever, is that they do not allow for control of the amyloid
Cell
56Figure 5. Jumping of Prion Transmission Barriers by the Sc4 Sup35 Amyloid Conformation In Vivo
(A) Species-specific induction of prion state expressing the indicated allele of SUP35 following transient overexpression of Sup-NMSc-GFP
or Sup-NMCa-GFP inducer protein. Shown is the number of [PSI+] colony forming units (CFU) per 105 cells plated.
(B) Efficiency of infection of yeast expressing the indicated allele of SUP35 by Sc4, Sc37, and spontaneously formed Sup-NMCa (Ca) amyloid
(10 M).
(C) Illustration of the prion strain phenotypes of Ca yeasts that are either prion-free (ca−) or contain prions formed spontaneously (CA+) or by
infection with Sc4 amyloid (CA+(Sc4)). The top and bottom show growth on YEPD and SD trace ADE plates, respectively. In each plate, top
and bottom spots show the strain phenotypes before or after passage on YEPD plates containing 3 mM Gdn-HCl.
(D) Infection of yeast expressing the indicated allele of SUP35 with partially purified prions (0.4 mg/ml) from the [PSI+(Sc4)] or [PSI+(Sc37)] strains
produced by the infection of Sc yeast with Sc4 or Sc37 amyloid, respectively.
(E) Illustration of the prion strain phenotypes of Ca yeasts that are either prion-free (ca−) or contain prions formed spontaneously (CA+) or by
infection with PSI+(Sc4) prions (CA+(PSI+(Sc4))) as in (D).
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on interspecies infectivity in vivo. To overcome this
limitation, we directly tested by protein infection the
ability of distinct amyloid conformations to cross the
Sc-Ca prion transmission barrier. As observed pre-
viously, both Sc4 and Sc37 but not Sup-NMCa amyloid
fibers are able to infect Sc yeast (Figure 5B, left). In
excellent agreement with the in vitro results described
above, we found that the Sc4 amyloid was indeed able
to infect Ca yeast (Figure 5B, right), while introduction
of the Sc37 amyloid did not induce prion conversion in
Ca yeast even at the maximal attainable fiber concen-
tration (40 M). Moreover, infection of Ca yeast strain
with Sc4 fibers led to a novel weak prion strain, termed
[CA+(Sc4)], characterized by a pink color phenotype on
YEPD plates and intermediate growth on adenine defi-
cient media, and, as expected for a prion state, was
curable by transient growth in the presence of guani-
dine hydrochloride (Gdn-HCl) (Figure 5C).
In order to confirm the observed strain-specific jump-
ing of the prion transmission barrier between the highly
divergent S. cerevisiae and C. albicans yeast proteins,
we infected yeast with different conformations of prion
particles purified from an in vivo source. We first in-
fected Sc yeast with in vitro-produced Sc4 or Sc37
amyloid yielding two different [PSI+] strains, termed
[PSI+(Sc4)] and [PSI+(Sc37)], respectively. Previously, we
established that Sup35 prion particles in the [PSI+(Sc4)]
and [PSI+(Sc37)] strains maintain the physical properties
of the in vitro-generated parent fibers (Tanaka et al.,
2004). We then partially purified Sup35 prion particles
from cell extracts of [PSI+(Sc4)] and [PSI+(Sc37)] strains
and examined their abilities to infect Sc and Ca yeast.
As we observed previously (Tanaka et al., 2004), prions
purified from both [PSI+(Sc4)] and [PSI+(Sc37)] strains can
infect Sc yeast (Figure 5D). As predicted by the above
in vitro seeding experiments, [PSI+(Sc4)] prions but not
[PSI+(Sc37)] prions could infect Ca yeast, although the
infection was less efficient than that seen with [CA+]
prions. Moreover, infection of Ca yeast with the
[PSI+(Sc4)] prions leads to a novel weak prion strain (Fig-
ure 5E), consistent with the results observed with pure
Sc4 fibers.
The in vitro seeding experiments suggest that tem-
plating of Ca Sup35 prions by Sc4 prions would lead to
a Ca conformation able to crosstransmit the infected
state back to Sc yeast. To directly test this prediction,
we created a prion state in Ca yeast, termed [CA+(Sc4)],
that had been templated in the Sc4 conformation by
infecting Ca yeast with pure Sc4 fibers as described
above. For comparison, we also prepared prions from
a Ca strain, [CA+(Ca)], which had been produced by in-
fection of Ca yeast with spontaneously generated Sup-
NMCa amyloid. As expected, prions from the [CA+(Ca)]
strain could readily infect Ca but not Sc yeast. In strik-
ing contrast, prions from [CA+(Sc4)] strain were able to
infect both Sc and Ca yeast with comparable efficiency
(Figure 6A). Infection of Sc yeast with [CA+(Sc4)]-derived
prions resulted in a novel strain markedly different from
that observed in Sc yeast directly infected with Sc4 fi-
bers (Figure 6B). The ability of [CA+(Sc4)] prions to infect
Sc yeast is particularly remarkable, as [CA+(Sc4)] is a
relatively weak strain (compared to [CA+(Ca)] strains,
[CA+(Sc4)] strains have a weak translation read-throughphenotype and decreased ability to infect Ca yeast
[Figures 5C and 6A]). Thus, the propensity of a given
prion strain to be transmitted to distantly related prion
proteins is independent of the strength of its strain phe-
notype or its prion titer. Neither the Sc4 nor the Ca[Sc4]
prions were able to induce conversion in F, a prion pro-
tein derived from an unrelated asparagines-rich prion
domain found in the yeast New1 protein (Osherovich et
al., 2004) (Figure 6C), thus arguing that crossinfection
does not result from a nonspecific increase in the pro-
pensity of the yeast to form prions. Taken together,
these results establish that the Sc4 and Ca[Sc4] prion
strains—by allowing cross-seeding between highly diver-
gent proteins—result in conformation-specific breaching
of the previously characterized strong Sc-Ca transmis-
sion barrier.
Discussion
Barriers inhibiting transmission of the infectious state
between different prion proteins are a characteristic
feature of prion inheritance. Both because of their
central role in prion biology and because of the practi-
cal importance of preventing interspecies disease
transmission, how such barriers arise and are breached
has been the subject of intense interest. Many of the
early efforts to understand transmission barriers fo-
cused on primary structure as a determinant of speci-
ficity. This focus now appears naive in light of the exis-
tence of the strain phenomenon. Infectious particles
composed of identical prion proteins can have mark-
edly different properties, including their propensity for
cross-species transmission (Collinge 2001; Chien et al.,
2004). The existence of distinct prion strains initially
posed a challenge to the protein-only hypothesis (Soto
and Castilla, 2004). We now know that such strain di-
versity can arise solely as a result of differences in the
infectious conformation of the prion protein (King and
Diaz-Avalos, 2004; Tanaka et al., 2004). Several studies
point to an intimate relationship among prion strains,
conformation of the infectious protein, and propensity
for cross-species transmission (Barron et al., 2001;
Chien and Weissman, 2001; Peretz et al., 2002; Chien
et al., 2003). Despite the existence of these studies, a
clear mechanistic understanding of how and why these
phenomena are related has remained obscure, largely
due to the difficulty of creating synthetic prions and
testing their infectivity.
In the present study, we have taken advantage of our
recently developed protein-infection protocol together
with the ability to produce distinct, self-propagating in-
fectious forms of Sup35, the protein determinant of the
yeast prion [PSI+], to directly explore the role of the
Sup35 amyloid conformations in interspecies prion
transmission. A major finding here is that particular am-
yloid conformations allow prion transmission back and
forth between distantly related S. cerevisiae and C. al-
bicans Sup35 proteins. In strong support for a central
role of amyloid conformation in prescribing transmis-
sion specificity, we found that the propensity of a given
prion strain to be transmitted to highly divergent spe-
cies is independent of either the strength of its strain
phenotype or its prion titer. This cross-species infection
Cell
58Figure 6. The Ca[Sc4] Strain Conformation
Can Crossinfect Sc Yeast In Vivo
(A) Infection of yeast expressing the indi-
cated allele of SUP35 with yeast extracts
(0.8 mg/ml) derived from CA+(Ca) and
CA+(Sc4) strains.
(B) In vivo phenotypes of resulting prion
strains. In the schematic, red arrows indicate
steps involving transmission between Sc
and Ca species, and black arrows indicate
intraspecies transmission. Typical pheno-
types of prion strains resulting from the
transmission event indicated by the numbers
were examined as described in Figures 5C
and 5E. Infection of Ca yeast with Sc4 fibers
exclusively induced a weak strain pheno-
type, shown in (2), while infection of Sc yeast
with Ca[Sc4] prions predominantly (w80%)
led to a very weak strain, shown in (3), as
well as intermediate strength similar to that
shown in (2) (w20%).
(C) Infection of yeast expressing a New1/Sc-
Sup35 chimeric prion protein, termed F
(Osherovich et al., 2004), with yeast extracts
(0.8 mg/ml) derived from PSI+(Sc4), PSI+(Sc37),
CA+, CA+(Sc4), and F yeasts that are prion-
free (f−) or contain prions formed spontane-
ously (F+).was unexpected in light of both the strong divergence p
S(w40% similarity in the prion domains) between the two
Sup35 proteins and the findings of earlier studies show- t
ting that spontaneously generated prion forms of these
two proteins show no apparent ability to crossinfect l
veach other (Santoso et al., 2000; Chien and Weissman,
2001). Specifically, we find that a distinct amyloid con- b
formation of Sc Sup35 prion protein formed in vitro is
able to infect yeast expressing Ca Sup35. Remarkably, l
cthis cross-species transmission generates a novelrion strain, which can in turn be transmitted back to
c yeast. In vitro studies with pure protein established
hat this cross-species infectivity is a direct result of
he ability of a specific conformation of Sc Sup35 amy-
oid to seed polymerization of the Ca protein and vice
ersa. Thus, even strong species barriers can be
ridged by specific prion strain conformations.
Our structural studies provide insights into the bio-
ogical differences between the different prion strain
onformations. EPR analysis, in particular, revealed lo-
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formations in the beginning and end of the prion do-
main and suggested that, in the Sc37 conformation, the
amyloid core is more highly ordered and that the struc-
tured region extends further into both the N terminus
and C terminus. This increase in structure is consistent
with the increased rigidity and thermal stability of the
Sc37 fibers relative to Sc4 amyloid, which in turn is re-
sponsible for the differences in the strain phenotypes
seen in vivo. The extended structure in the Sc37 con-
formation also helps explain the earlier observation
(Bradley and Liebman, 2004) that propagation of strain
differences requires residues beyond amino acid 124
even though this region is dispensable for prion inheri-
tance. Finally, the structural difference in the N- and
C-terminal regions may play a critical role in altering the
ability of a given prion strain to cross-species barriers,
as the EPR studies indicate that these regions are in-
volved in intermolecular contacts in the Sup35 prion.
Given the ability of different prion strain conforma-
tions to alter the specificity of prion transmission, what,
then, is the role of primary structure in determining the
propensity of transmission between donor and host
prion proteins? The critical importance of a given strain
conformation in modulating a prion’s seeding specific-
ity together with the ubiquitous nature of prion strains
suggests a model in which the primary structure acts
predominantly to modulate the range of infectious prion
conformations, and the specific conformation in turn
determines the ability to be transmitted across a spe-
cies barrier (Figure 7). A common feature of amyloid-
forming proteins is that a single protein can adopt mul-Figure 7. Venn Diagram Illustrating Relation-
ship between Primary Structure of Prion Pro-
teins, Spectrum of Preferred Prion Confor-
mations and Capacity for Cross-Species
Transmission
Each prion protein will have a spectrum of
allowed prion conformations. For distantly
related proteins, there may be no overlap-
ping conformations resulting in absolute
transmission barriers (top). For more related
sequences, the degree of overlap increases
as the similarity between the two proteins in-
creases, thereby leading to an increase in
the number of strain conformations that al-
low cross-species transmission (middle and
bottom).tiple distinct, self-propagating amyloid conformations
with the spectrum of misfolded forms being determined
by the protein’s primary structure (Dobson 2001; Chien
et al., 2004; Petkova et al., 2005). Thus, an absolute
transmission barrier between two divergent species of
prion proteins would exist only in the extreme case
when two proteins have completely nonoverlapping
spectra of allowed prion conformations. More gen-
erally, it would be expected that related but divergent
proteins share a subset of conformations. This model
predicts that crosstransmission will be possible for
some subset of the accessible prion strain conforma-
tions, whereas, for the other conformations, a robust
species barrier will prevent interspecies infection. As
two protein sequences become more divergent, the
number of overlapping conformations will decrease,
and thus the probability of crossing a species barrier
will decrease.
This view that primary structure determines prion
specificity in large part by altering the spectrum of al-
lowed prion conformations provides insight into a num-
ber of otherwise puzzling features of cross-species
prion transmission. For example, this model helps to
explain why in both yeast and mammalian prions point
mutations or allelic variants can have dramatic effects
on the specificity of prion transmission in a strain-spe-
cific manner (Bossers et al., 1997; Manson et al., 1999;
Barron et al., 2001; King, 2001; Chien et al., 2003; Baylis
and McIntyre, 2004), as the range of conformations fa-
vored by a prion protein can be strongly influenced by
even small changes in the primary structure. In support
of this, it has recently been shown that the M129/V129
Cell
60Icodon in human prion protein is critical in determining
Sstrain phenotypes and susceptibility to BSE-derived
pprions (Wadsworth et al., 2004). This model also sug-
e
gests an explanation for the observed ability of Sup35 1
derived from some non-Sc species to cross-seed Sc P
Dprotein (Chernoff et al., 2000; Nakayashiki et al., 2001).
rOf particular interest was the finding that overexpres-
msion of Pichia methanolic Sup35 at lower but not ele-
Pvated temperatures can induce prion formation in Sc
2
yeast (Chernoff et al., 2000). P. Methanolica Sup35 is W
known to support a range of different prion strains t
f(Kushnirov, et al., 2000a). In light of the above consider-
8ations, it is possible that temperature is acting to con-
fstrain the amyloid conformations formed spontane-
uously by P. Methanolica Sup35. The resulting range of
x
strains would in turn determine whether cross-species a
transmission to the Sc protein is favored. More gen- c
aerally, even with noninfectious protein aggregates, such
pas those associated with a range of neurodegenerative
Fdiseases, the specific amyloid conformation adopted
aby a protein is likely to play an important role in deter-
t
mining its abilities to recruit heterologous proteins, l
thereby modulating the toxic effects of accumulating 1
pmisfolded forms.
DIn addition to elucidating the link between prion
mstrains and transmission barriers, the present studies
Cillustrate the existence of an intimate link between in-
f
terspecies transmission of prions and the development i
of novel prion strains. Passage of a specific Sc amyloid N
wto Ca yeast resulted in the emergence of a novel strain
tin vivo and the formation of a distinct amyloid confor-
Smation in vitro. This newly generated Ca conformation
bcan infect both Sc and Ca species of Sup35 proteins
s
and induces yet another Sc prion strain distinct from 2
the strain of the originally infected Sc yeast. Structural 1
manalyses including FT-IR and EPR spectroscopies di-
lrectly demonstrated that passage of the prion from Sc
wto Ca and back to Sc resulted in a novel infectious con-
n
formation. These results are analogous to the observa- t
tion that the infrequent cross-species transmission of s
mammalian prions between species with distinct prion
protein genes leads to the emergence of new prion I
ostrains with distinct conformations (Peretz et al., 2002).
IMore speculatively, cross-species prion infections may
(play an important role in promoting especially virulent
w
forms of prions, such as those responsible for mad cow i
disease or new variant of Creutzfeldt-Jacob disease, g
by generating more promiscuous prion conformations c
bthat are compatible with a wide range of related
pspecies.
S
Experimental Procedures
S
SConstruction of Plasmids and Yeast Strains
mConstruction of bacterial and copper-inducible expression vectors
hfor the various forms of Sup-NM was reported previously (Santoso
et al., 2000). Isogenic [psi−][pin+] and [PSI+] derivatives of 74D-694
yeast (his3, leu2, trp1, ura3; suppressible marker ade1-14[UGA])
(Chernoff et al., 1995; Santoso et al., 2000) were used for Sup-NM- A
GFP overexpression and infection experiments. Construction of
Ca, Chim, and F yeasts that express Sup35 chimeric proteins fused W
to S. cerevisiae Sup35 middle and C-terminal domains from the H
wild-type SUP35 chromosomal locus was described previously J
o(Santoso et al., 2000; Osherovich et al., 2004).n Vitro Analysis of Sup-NM Amyloid Fibers
up-NM proteins with polyhistidine tags at the C terminus were
roduced in bacteria and purified as reported previously (Santoso
t al., 2000), except in the case of the cysteine mutants, in which
mM β-mercaptoethanol was included in all purification buffers.
reparation of Sup-NM amyloid fibers is described in Supplemental
ata. Amyloid fiber formation was monitored by thioflavine T fluo-
escence using a 96-well plate reader (Chien et al., 2003). The ther-
al stability of amyloid fibers (2.5 M) was examined by SDS-
AGE (7.5% or 4%–12% gradient gel [Invitrogen] [Chien et al.,
003]). Thermally solubilized monomeric Sup-NM was detected by
estern blotting with a polyclonal anti-Sup-NMSc antibody (San-
oso et al., 2000), which reacts with both Sup-NMSc and Sup-NMCa,
ollowed by detection with chemiluminescence using a FluorChem
800 (Alpha Innotech). The band intensities in Western blots were
itted to a sigmoidal curve with IgorPro3.0 (WaveMetrics, Inc.),
sing the following equation: y = A + B/(1 + 10^((C − x)/D)), where
, y, C, and D indicate temperature, band intensity, melting (Tm),
nd transition (W) temperatures, respectively. For FT-IR spectros-
opy, Sc4 and Sc37 amyloids were spontaneously formed at 4°C
nd 37°C, respectively, and Sc[Ca3[Sc4]] amyloid was prepared by
olymerizing Sc Sup-NM with 5% (wt/wt) seed of Ca3[Sc4] fibers.
T-IR spectra of the amyloid fibers (w100 g) were recorded with
Perkin Elmer (Norwalk, CT) System FT-IR 2000 spectrophotome-
er with a microscope attachment at 23°C. Each spectrum was col-
ected with a 2 cm−1 resolution and a 1 cm−1 interval from 1750 to
550 cm−1. Secondary structure contents were estimated as re-
orted previously (Wille and Prusiner, 1999). See Supplemental
ata for details. For EPR spectroscopy, Sup-NM single cysteine
utants were labeled by MTSL (5 equivalents) (Toronto Research
hemicals Inc.) (Hubbell et al., 2000) with >80% efficiency and puri-
ied as previously reported (Tanaka et al., 2004). Absence of label-
ng at noncysteine residues was confirmed using wild-type Sup-
M that lacks cysteine residues. Sc4, Sc37, and Sc[Ca3[Sc4]] fibers
ere formed at 4°C, 37°C, and 23°C by polymerizing Sup-NM cys-
eine mutants with 5% (wt/wt) seed of spontaneously formed Sc4,
c37 amyloids, and Sc[Ca3[Sc4]] amyloid, respectively. Pelleted fi-
rillar Sup-NM (w50 g) was loaded onto a flatcell, and EPR
pectra were measured with a Bruker EMX EPR spectrometer at
3°C with 25 mW microwave power and a modulation of 1.0 G at
00 KHz over a scan range of 100 or 200 G. For dilution experi-
ents, spin-labeled Sup-NM cysteine mutants were mixed with un-
abeled wild-type protein in a 1:1 molar ratio. The use of MTSL,
hich is smaller than 4-Maleimido-2,2,6,6-tetramethyl-1-piperidi-
yloxy (Tanaka et al., 2004), together with a modulation of 1.0 G in
he EPR spectrometer substantially improved the resolution of EPR
pectra, compared with that in our earlier work (Tanaka et al., 2004).
n Vivo Analysis of Cross-Species Transmission
f Sup-NM Prions
nduction experiments were carried out as previously described
Santoso et al., 2000). Briefly, Sup-NMSc-GFP and Sup-NMCa-GFP
ere overexpressed from a 2 plasmid driven from a copper-induc-
ble CUP1 promoter (Santoso et al., 2000). Transformants were
rown on SD-URA media containing 50 M CuSO4 for 24 hr. These
ultures were plated on SD-ADE and SD complete plates, and visi-
le colonies were counted after about 7 days. Protein infection ex-
eriments were carried out by the procedure of Tanaka et al. (2004).
ee Supplemental Data for details.
upplemental Data
upplemental Data include three figures and Supplemental Experi-
ental Procedures and can be found with this article online at
ttp://www.cell.com/cgi/content/full/121/1/49/DC1/.
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